The hallmark study of Kaplan et al. served first proof for a lung premetastatic niche formation in melanoma, which is made possible by BMDCs that—just as melanomas—express VLA-4 (α4β1-integrin), a known fibronectin ligand [210, 215]. The gene discussed is FN1; the disease is melanoma.